在乳腺癌中使用受控卵巢刺激保存生育能力:对新辅助和辅助设置的比较研究
Moran Shapira1,2, Chen Berkovitz3, Myriam Safrai4,5
1IVF Institute, Sheba Medical Center, Ramat Gan, Israel. Shapira.moran@gmail.com.
Journal of assisted reproduction and genetics
|February 20, 2026
概括
乳腺癌患者的生育能力保护 (FP) 在新辅助化疗 (NAC) 和辅助化疗 (AC) 设置中都是可行的. 虽然NAC允许更快的FP启动,但癌症治疗时间表和FP结果在NAC和AC组之间仍然可比.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 在瘤学瘤学.
- 在生育能力上.
背景情况:
- 保护生育能力 (FP) 对年轻的乳腺癌患者至关重要.
- 在新辅助化疗 (NAC) 和辅助化疗 (AC) 环境中比较FP结果对于治疗规划很重要.
研究的目的:
- 为了比较第一次治疗开始的时间和受控卵巢刺激 (COS) 的结果,乳腺癌患者在NAC和AC环境中接受FP.
主要方法:
- 对经过FP随机开始COS的1-3期乳腺癌患者进行回顾性队列研究 (2015-2023).
- 在NAC和AC组之间对基线,瘤和COS特征和结果进行比较.
- 计算与癌症诊断,FP和第一次瘤干预相关的时间点.
主要成果:
- 分析了70名NAC患者和42名AC患者;NAC患者的疾病更为晚期.
- 在NAC组中,从诊断到FP咨询和刺激开始的时间明显较短.
- 刺激特征和卵细胞检索/受精率相似,NAC组的M2卵细胞数量较高.
结论:
- 在NAC环境中加快FP护理导致癌症治疗的延迟最小.
- 与AC相比,在NAC环境中,瘤治疗时间表和FP结果没有受到影响.
相关概念视频
Infertility in Females
4.9K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
4.9K
Hormonal Control of the Ovarian Cycle
7.1K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.1K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K


